Rogosnitzky
Moshe Rogosnitzky, Telz Stone IL
Patent application number | Description | Published |
---|---|---|
20110104246 | METHOD OF WOUND TREATMENT USING LIQUID GALLIUM NITRATE - A pharmaceutical composition and method for topical wound treatment by topical treatment with gallium salts, preferably gallium nitrate. In a preferred embodiment, the gallium nitrate is in an aqueous form without coagulation inhibitors such as citrate. The aqueous gallium salt formulation may be administered by a variety of methods including spraying, topical lotions, topical foams, and/or bandages containing or packaged with breakable ampoules of aqueous gallium salt formulations, and liquid bandage formulations. The aqueous gallium salt formulation may additionally contain other active and inactive ingredients, such as viscosity modifying agents, foaming agents, antiseptics, antibiotics, enzymes, fibrinogen, fibrin, polymers and growth factors. | 05-05-2011 |
Moshe Rogosnitzky, Kriat Ya'Arim IL
Patent application number | Description | Published |
---|---|---|
20140275124 | METHODS FOR TREATING EYE DISORDERS USING DIPYRIDAMOLE - The present invention discloses methods for treating eye disorders. The methods include the step of administering an effective amount of a topically-administered dipyridamole. Preferably, the topically-administered dipyridamole is formulated as a solution. Preferably, the topically-administered dipyridamole is at least one agent selected from the group consisting of: dipyridamole, and a pharmaceutically-acceptable salt thereof. Preferably, the effective amount corresponds to a concentration of at least about 10 | 09-18-2014 |
Moshe Rogosnitzky, Kiryat Yearim IL
Patent application number | Description | Published |
---|---|---|
20150031712 | Therapeutic Compositions Containing Dipyridamole and Treatment Packs Including Such Compositions and Methods for Producing Same - A treatment pack comprising: (a) multiple doses of a composition containing dipyridamole as an active ingredient; (b) packaging material; and (c) instructions for topical administration of said composition to the anterior segment of the eye to treat an anterior segment eye disorder. | 01-29-2015 |